Risk factors for liver fibrosis among human immunodeficiency virus monoinfected patients using the FIB4 index in Morocco

World Journal of Hepatology

Volumn 5, Issue 10, 2013, Pages 584-588

  Tahiri, Mohamed ^a   Sodqi, Mustapha ^a   Lahdami, Fatima Ez Zahra ^a   Marih, Latifa ^a   Lamdini, Hassan ^a   Hliwa, Wafaa ^a   Lahcen, Ahd Oulad ^a   Badre, Wafaa ^a   Haddad, Fouad ^a   Chakib, Abdelfetah ^a   Bellabah, Ahmed ^a   Alaoui, Rhimou ^a   El Filali, Kamal Marhoum ^a  

^a IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

Author keywords

FIB4; Human immunodeficiency virus; Liver; Monoinfected; Risk factors

Indexed keywords

EID: 84887356012     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v5.i10.584     Document Type: Article

References (33)

1. Smith C, Sabin CA, Lundgren JD, Thiebaut R, Weber R, Law M, Monforte Ad, Kirk O, Friis-Moller N, Phillips A, Reiss P, El Sadr W, Pradier C, Worm SW. Factors associated with specific causes of death amongst HIV-positive individuals in the D: A: D Study. AIDS 2010; 24: 1537-1548 [PMID: 20453631 DOI: 10.1097/QAD.0b013e32833a0918]
2. Crane M, Iser D, Lewin SR. Human immunodeficiency virus infection and the liver. World J Hepatol 2012; 4: 91-98 [PMID: 22489261 DOI: 10.4254/wjh.v4.i3.91]
3. Moodie EE, Pant Pai N, Klein MB. Is antiretroviral therapy causing long-term liver damage? A comparative analysis of HIV-mono-infected and HIV/hepatitis C co-infected cohorts. PLoS One 2009; 4: e4517 [PMID: 19223976 DOI: 10.1371/journal. pone.0004517]
4. Castellares C, Barreiro P, Martín-Carbonero L, Labarga P, Vispo ME, Casado R, Galindo L, García-Gascó P, García-Samaniego J, Soriano V. Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome. J Viral Hepat 2008; 15: 165-172 [PMID: 18233989 DOI: 10.1111/j.1365-2893.2007.00903.x]
5. Sulkowski MS, Mehta S, Montes de Occa R, Moore RD. Thomas DL: Estimated prevalence of significant liver disease among 4,052 HIVinfected adults with and without chronic hepatitis B and C. 13th Conference on Retroviruses and Opportunistic Infections; 2006 February 5-8; Denver, CO, USA. 2006: abstr 842
6. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, Sulkowski M, Torriani FJ, Dieterich DT, Thomas DL, Messinger D, Nelson M. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006; 43: 1317-1325 [PMID: 16729309]
7. Blackard JT, Welge JA, Taylor LE, Mayer KH, Klein RS, Celentano DD, Jamieson DJ, Gardner L, Sherman KE. HIV mono-infection is associated with FIB-4-A noninvasive index of liver fibrosis - in women. Clin Infect Dis 2011; 52: 674-680 [PMID: 21248367 DOI: 10.1093/cid/ciq199]
8. Tedaldi EM, Baker RK, Moorman AC, Alzola CF, Furhrer J, McCabe RE, Wood KC, Holmberg SD. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2003; 36: 363-367 [PMID: 12539079]
9. Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, Snydman DR. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001; 32: 492-497 [PMID: 11170959]
10. DallaPiazza M, Amorosa VK, Localio R, Kostman JR, Lo Re V. Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients. BMC Infect Dis 2010; 10: 116 [PMID: 20465840 DOI: 10.1186/1471-2334-10-116]
11. Chang PE, Miquel R, Blanco JL, Laguno M, Bruguera M, Abraldes JG, Bosch J, Garcia-Pagan JC. Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy. Am J Gastroenterol 2009; 104: 1707-1714 [PMID: 19471257 DOI: 10.1038/ajg.2009.165]
12. Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C, Zilmer K, Vella S, Kirk O, Lundgren JD. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 2005; 19: 593-601 [PMID: 15802978]
13. Tatsunami S, Taki M, Shirahata A, Mimaya J, Yamada K. Increasing incidence of critical liver disease among causes of death in Japanese hemophiliacs with HIV-1. Acta Haematol 2004; 111: 181-184 [PMID: 15153708]
14. Selik RM, Byers RH, Dworkin MS. Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999. J Acquir Immune Defic Syndr 2002; 29: 378-387 [PMID: 11917243]
15. Weber R, Sabin CA, Friis-Møller N, Reiss P, El-Sadr WM, Kirk O, Dabis F, Law MG, Pradier C, De Wit S, Akerlund B, Calvo G, Monforte Ad, Rickenbach M, Ledergerber B, Phillips AN, Lundgren JD. Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study. Arch Intern Med 2006; 166: 1632-1641 [PMID: 16908797]
16. Gebo KA, Diener-West M, Moore RD. Hospitalization rates differ by hepatitis C satus in an urban HIV cohort. J Acquir Immune Defic Syndr 2003; 34: 165-173 [PMID: 14526205]
17. Mata-Marin JA, Gaytan-Martinez JE, Grados-Chavarria BH, Fuentes-Allen JL, Arroyo-Anduiza CI, Alfaro-Mejia A. Correlation between HIV viral and aminotransferases as liver damage markers in HIV infected naive patients: a concordance cross-sectional study. Virol J 2009; 6: 181
18. Bräu N, Salvatore M, Ríos-Bedoya CF, Fernández-Carbia A, Paronetto F, Rodríguez-Orengo JF, Rodríguez-Torres M. Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol 2006; 44: 47-55 [PMID: 16182404]
19. Qurishi N, Kreuzberg C, Lüchters G, Effenberger W, Kupfer B, Sauerbruch T, Rockstroh JK, Spengler U. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet 2003; 362: 1708-1713 [PMID: 14643119]
20. Bonacini M, Louie S, Bzowej N, Wohl AR. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. AIDS 2004; 18: 2039-2045 [PMID: 15577625]
21. Hufert FT, Schmitz J, Schreiber M, Schmitz H, Rácz P, von Laer DD. Human Kupffer cells infected with HIV-1 in vivo. J Acquir Immune Defic Syndr 1993; 6: 772-777 [PMID: 8099611]
22. Gendrault JL, Steffan AM, Schmitt MP, Jaeck D, Aubertin AM, Kirn A. Interaction of cultured human Kupffer cells with HIV-infected CEM cells: an electron microscopic study. Pathobiology 1991; 59: 223-226 [PMID: 1883517]
23. Schmitt MP, Gendrault JL, Schweitzer C, Steffan AM, Beyer C, Royer C, Jaeck D, Pasquali JL, Kirn A, Aubertin AM. Permissivity of primary cultures of human Kupffer cells for HIV-1. AIDS Res Hum Retroviruses 1990; 6: 987-991 [PMID: 2121193]
24. Ocama P, Castelnuovo B, Kamya MR, Kirk GD, Reynolds SJ, Kiragga A, Colebunders R, Thomas DL. Low frequency of liver enzyme elevation in HIV-infected patients attending a large urban treatment centre in Uganda. Int J STD AIDS 2010; 21: 553-557 [PMID: 20975087 DOI: 10.1258/ijsa.2010.010027]
25. Tan AT, Koh S, Goh W, Zhe HY, Gehring AJ, Lim SG, Bertoletti A. A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B. J Hepatol 2010; 52: 330-339 [PMID: 20137825 DOI: 10.1016/j.jhep.2009.12.015]
26. Zhang YX, Gui XE, Zhong YH, Rong YP, Yan YJ. Cancer in cohort of HIV-infected population: prevalence and clinical characteristics. J Cancer Res Clin Oncol 2011; 137: 609-614 [PMID: 20532560 DOI: 10.1007/s00432-010-0911-y]
27. Tuyama AC, Hong F, Saiman Y, Wang C, Ozkok D, Mosoian A, Chen P, Chen BK, Klotman ME, Bansal MB. Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1expression: implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis. Hepatology 2010; 52: 612-622
28. Torre D, Pugliese A. Platelets and HIV-1 infection: old and new aspects. Curr HIV Res 2008; 6: 411-418 [PMID: 18855651]
29. Forrester JE, Rhee MS, McGovern BH, Sterling RK, Knox TA, Terrin N. The association of HIV viral load with indirect markers of liver injury. J Viral Hepat 2012; 19: e202-e211 [PMID: 22239520 DOI: 10.1111/j.1365-2893.2011.01529.x]
30. Mendeni M, Focà E, Gotti D, Ladisa N, Angarano G, Albini L, Castelnuovo F, Carosi G, Quiros-Roldan E, Torti C: Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection. Clin Infect Dis 2011; 52: 1164-1173 [DOI: 10.1093/cid/cir071]
31. Pineda JA, González J, Ortega E, Tural C, Macías J, Griffa L, Burgos A. Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients. J Viral Hepat 2010; 17: 714-719 [PMID: 20002560 DOI: 10.1111/j.1365-2893.2009.01229.x]
32. Mayer KH, Hogan JW, Smith D, Klein RS, Schuman P, Margolick JB, Korkontzelou C, Farzedegan H, Vlahov D, Carpenter CC. Clinical and immunologic progression in HIV-infected US women before and after the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2003; 33: 614-624 [PMID: 12902807]
33. Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, Fontaine H, Pol S. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology 2007; 46: 32-36 [PMID: 17567829]